tiprankstipranks
Trending News
More News >
Everest Medicines Ltd. (HK:1952)
:1952
Hong Kong Market

Everest Medicines Ltd. (1952) Income Statement

Compare
4 Followers

Everest Medicines Ltd. Income Statement

Last quarter (Q2 2025), Everest Medicines Ltd.'s total revenue was ¥223.06M, an increase of 47.96% from the same quarter last year. In Q2, Everest Medicines Ltd.'s net income was ¥-124.89M. See Everest Medicines Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
¥ 706.68M¥ 125.93M¥ 12.79M¥ 54.00K¥ 0.00
Gross Profit
¥ 528.89M¥ 91.52M¥ 8.15M¥ 31.00K¥ 0.00
Operating Expenses
¥ 1.65B¥ 1.02B¥ 264.95M¥ 1.03B¥ 687.41M
Depreciation and Amortization
¥ 110.17M¥ 76.78M¥ 42.77M¥ 31.12M¥ 4.48M
EBITDA
¥ -670.04M¥ -744.63M¥ -198.91M¥ -972.78M¥ -683.03M
Operating Income
¥ -1.12B¥ -932.74M¥ -256.80M¥ -1.03B¥ -688.46M
Other Income/Expenses
¥ 75.67M¥ 88.28M¥ 9.53M¥ 17.61M¥ -4.97B
Pretax Income
¥ -1.04B¥ -844.46M¥ -247.28M¥ -1.01B¥ -5.66B
Net Income
¥ -1.04B¥ -844.46M¥ -247.28M¥ -1.01B¥ -5.68B
Per Share Metrics
Basic EPS
¥ -3.24¥ -2.70¥ -0.83¥ -3.44¥ -26.46
Diluted EPS
¥ -3.24¥ -2.70¥ -0.83¥ -3.44¥ -26.46
Weighted Average Shares Outstanding
320.92M 313.06M 297.63M 293.23M 214.75M
Weighted Average Shares Outstanding (Diluted)
320.92M 313.06M 297.63M 293.27M 214.75M
Currency in CNY

Everest Medicines Ltd. Earnings and Revenue History